CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy (vol 139, pg 95, 2013)

被引：0
|
作者：
Teft, Wendy A. [1 ]
Gong, Inna Y. [1 ,2 ]
Dingle, Brian [3 ]
Potvin, Kylea [3 ]
Younus, Jawaid [3 ]
Vandenberg, Theodore A. [3 ]
Brackstone, Muriel [3 ,4 ]
Perera, Francisco E. [3 ]
Choi, Yun-Hee [5 ]
Zou, Guangyong [5 ]
Legan, Robin M. [1 ]
Tirona, Rommel G. [1 ,2 ]
Kim, Richard B. [1 ,2 ,3 ,6 ]
机构：
[1] Univ Western Ontario, Dept Med, Div Clin Pharmacol, London, ON, Canada
[2] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada
[3] Univ Western Ontario, Dept Oncol, London, ON, Canada
[4] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada
[5] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada
[6] LHSC Univ Hosp, Dept Med, London, ON N6A 5A5, Canada
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2013年 / 142卷 / 01期
关键词：
D O I：
10.1007/s10549-013-2706-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
  • [1] CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy
    Wendy A. Teft
    Inna Y. Gong
    Brian Dingle
    Kylea Potvin
    Jawaid Younus
    Theodore A. Vandenberg
    Muriel Brackstone
    Francisco E. Perera
    Yun-Hee Choi
    Guangyong Zou
    Robin M. Legan
    Rommel G. Tirona
    Richard B. Kim
    Breast Cancer Research and Treatment, 2013, 139 : 95 - 105
  • [2] CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy
    Teft, Wendy A.
    Gong, Inna Y.
    Dingle, Brian
    Potvin, Kylea
    Younus, Jawaid
    Vandenberg, Theodore A.
    Brackstone, Muriel
    Perera, Francisco E.
    Choi, Yun-Hee
    Zou, Guangyong
    Legan, Robin M.
    Tirona, Rommel G.
    Kim, Richard B.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (01) : 95 - 105
  • [3] Erratum to: CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy
    Wendy A. Teft
    Inna Y. Gong
    Brian Dingle
    Kylea Potvin
    Jawaid Younus
    Theodore A. Vandenberg
    Muriel Brackstone
    Francisco E. Perera
    Yun-Hee Choi
    Guangyong Zou
    Robin M. Legan
    Rommel G. Tirona
    Richard B. Kim
    Breast Cancer Research and Treatment, 2013, 142 : 225 - 225
  • [4] Influence of CYP2D6 and CYP3A4 Phenotypes, Drug Interactions, and Vitamin D Status on Tamoxifen Biotransformation
    Antunes, Marina V.
    da Fontoura Timm, Tatiana Aparecida
    de Oliveira, Vanessa
    Staudt, Dilana E.
    Raymundo, Suziane
    Goessling, Gustavo
    Biazus, Jorge V.
    Cavalheiro, Jose A.
    Rosa, Daniela D.
    Wallemacq, Pierre
    Haufroid, Vincent
    Linden, Rafael
    Schwartsmann, Gilberto
    THERAPEUTIC DRUG MONITORING, 2015, 37 (06) : 733 - 744
  • [5] CYP2D6 and CYP3A influence tamoxifen and endoxifen
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (05) : 524 - 525
  • [6] Therapeutic Drug Monitoring of endoxifen as an alternative for CYP2D6 genotyping in individualizing tamoxifen therapy
    Schultink, Aurelia H. M. de Vries
    Huitema, Alwin D. R.
    Beijnen, Jos H.
    BREAST, 2018, 42 : 38 - 40
  • [7] CYP2D6 and Endoxifen in Tamoxifen Therapy: A Tribute to David A. Flockhart
    Skaar, Todd C.
    Desta, Zeruesenay
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (05) : 755 - 757
  • [8] Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol
    Fang, J
    Baker, GB
    Silverstone, PH
    Coutts, RT
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 1997, 17 (02) : 227 - 233
  • [9] Involvement of CYP3A4 and CYP2D6 in the Metabolism of Haloperidol
    Jian Fang
    Glen B. Baker
    Peter H. Silverstone
    Ronald T. Coutts
    Cellular and Molecular Neurobiology, 1997, 17 : 227 - 233
  • [10] Hydroxychloroquine is metabolized by CYP2D6, CYP3A4 and CYP2C8, and inhibits CYP2D6, while its metabolites also inhibit CYP3A4 in vitro
    Paludetto, M.
    Kurkela, M.
    Kahma, H.
    Backman, J.
    Niemi, M.
    Filppula, A.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S78 - S78
12345